Alzheimer disease and other dementias (ADOD) have a substantial impact on the prevalence and costs of certain comorbid conditions compared with matched beneficiaries without ADOD.
Dirk Soenksen, MS, MBA
Advertisement
Articles by Dirk Soenksen, MS, MBA
Advertisement
Latest Updated Articles
- Impact of Dementia on Costs of Modifiable Comorbid Conditions
November 8th 2018
Advertisement
Advertisement
Trending on AJMC
1
Daraxonrasib Clears FDA as First RAS-Targeted Pancreatic Cancer Drug
2
As GLP-1 Costs Climb, Medicare Part D Plans Face a Reckoning
3
Grocery Assistance Benefit Linked to Fewer Diabetes Complications
4
New York Experts Push for Coordinated Obesity Care Teams
5